Cours Ocera Therapeutics Inc

Actions

02/11/17	Levi & Korsinsky, LLP Notifies Investors of an Investigation Concerning Whether the Sale of Ocera Therapeutics, Inc. to Mallinckrodt plc is Fair to Shareholders
20/10/17	Ocera Presents Three Posters and an Oral Presentation on OCR-002 at the AASLD Liver Meeting®
23/08/17	Ocera Therapeutics Selected to Present an Oral Presentation and Three Posters on OCR-002 at the AASLD Liver Meeting® 2017
01/08/17	Ocera Therapeutics Reports Second Quarter 2017 Financial Results
01/06/17	Ocera Initiates Phase 2a Study with Oral OCR-002 in Patients with Cirrhosis

Ajouter à une liste 0 sélectionné Pour utiliser cette fonction vous devez être client ou membre Connexion Inscription	Varia.	Varia. 5j.	Varia. 1an	Varia. 3ans	Capi.($)
OCERA THERAPEUTICS INC	-.--%	+2,29%	-	-	0
REGENERON PHARMACEUTICALS, INC.	+1,63%	-2,74%	+17,91%	-18,09%	62,21 Md
UCB	+1,51%	+5,36%	+68,14%	+223,61%	59,45 Md
SAMSUNG BIOLOGICS CO.,LTD.	-0,92%	+28,60%	+28,60%	+28,60%	38,9 Md
CSL LIMITED	+0,26%	+9,80%	-55,40%	-65,15%	36,4 Md
BIOGEN INC.	+2,94%	+1,79%	+50,28%	-35,26%	29,52 Md
INCYTE CORPORATION	+2,32%	+6,51%	+56,62%	+76,65%	21,54 Md
MODERNA, INC.	+7,94%	-3,78%	+78,88%	-59,73%	19,7 Md
INNOVENT BIOLOGICS, INC.	+4,80%	-0,20%	-5,33%	+112,95%	16,18 Md
SWEDISH ORPHAN BIOVITRUM AB	-0,02%	-1,61%	+49,86%	+101,56%	15,89 Md
Moyenne	+2,04%	+1,46%	+32,17%	+40,57%	33,31 Md
Moyenne pondérée par Capi.	+1,78%	+1,87%	+30,77%	+45,98%